CHARACTERIZATION OF THE SECRETED, NATIVE GP120 AND GP160 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:86
|
作者
KALYANARAMAN, VS
RODRIGUEZ, V
VERONESE, F
RAHMAN, R
LUSSO, P
DEVICO, AL
COPELAND, T
OROSZLAN, S
GALLO, RC
SARNGADHARAN, MG
机构
[1] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
[2] NCI,FREDERICK CANC RES FACIL,BRI BASIC RES PROGRAM,FREDERICK,MD 21701
关键词
D O I
10.1089/aid.1990.6.371
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously shown that the cell line 6D5451 chronically infected with the HIV-1 isolate HTLV-III451, secretes the HIV-1 envelope glycoproteins gp120 and gp160 in the extracellular medium. The HTLV-III451 gp120 and gp160 were purified by sequential affinity Chromatographic steps using a monoclonal antibody to HIV-1 gp41 and an anti-HIV-1-positive human serum. Amino acid sequence analysis of gp120 and gp160 showed the loss of the signal peptide. Digestion of the purified gp120 and gp160 with endoglycosidases revealed that both proteins are heavily glycosylated and contain complex carbohydrates, in contrast to the intracellular form of gp160 which has been shown to contain mannose-rich immature sugars. Competitive binding analysis showed that while both gp120 and gp160 bind CD4, the affinity of gp160 was five times lower than that of gp120. Both gp120 and gp160 inhibited syncytia formation by HIV-1-infected cells when mixed with CD4+ cells. Furthermore, both gp120 and gp160 had strong mitogenic effects on the T cells from HIV-1-infected gibbons but not on cells from uninfected gibbons. © 1990, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 50 条
  • [21] THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS
    DOLIN, R
    GRAHAM, BS
    GREENBERG, SB
    TACKET, CO
    BELSHE, RB
    MIDTHUN, K
    CLEMENTS, ML
    GORSE, GJ
    HORGAN, BW
    ATMAR, RL
    KARZON, DT
    BONNEZ, W
    FERNIE, BF
    MONTEFIORI, DC
    STABLEIN, DM
    SMITH, GE
    KOFF, WC
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) : 119 - 127
  • [22] DIFFERENT PROLIFERATIVE RESPONSE OF HUMAN AND CHIMPANZEE LYMPHOCYTES AFTER CONTACT WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120
    DIRIENZO, AM
    FURLINI, G
    OLIVIER, R
    FERRIS, S
    HEENEY, J
    MONTAGNIER, L
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (01) : 34 - 40
  • [23] Characterization and enhancement of the interaction between HIV-1 gp120/gp160 and MBL
    Hart, ML
    Saifuddin, M
    Spear, GT
    FASEB JOURNAL, 2001, 15 (04): : A691 - A691
  • [24] PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE RELATIVELY RESISTANT TO NEUTRALIZATION BY MONOCLONAL-ANTIBODIES TO GP120, AND THEIR NEUTRALIZATION IS NOT PREDICTED BY STUDIES WITH MONOMERIC GP120
    MOORE, JP
    CAO, YZ
    QING, L
    SATTENTAU, QJ
    PYATI, J
    KODURI, R
    ROBINSON, J
    BARBAS, CF
    BURTON, DR
    HO, DD
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 101 - 109
  • [25] AFFINITY-PURIFIED, OLIGOMERIC HIV-1 GP160 INDUCES BROADLY NEUTRALIZING ANTIBODIES PREFERENTIALLY REACTIVE WITH NATIVE GP120/GP160
    VANCOTT, TC
    KAMINSKI, R
    MASCOLA, J
    KALYANARAMAN, V
    COX, J
    POLONIS, V
    VEIT, S
    ETTORE, C
    HALLBERG, P
    PATEL, L
    LOWELL, G
    BURKE, D
    RECHTMAN, D
    BIRX, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S150 - S150
  • [26] A FURIN-DEFECTIVE CELL-LINE IS ABLE TO PROCESS CORRECTLY THE GP160 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    OHNISHI, Y
    SHIODA, T
    NAKAYAMA, K
    IWATA, S
    GOTOH, B
    HAMAGUCHI, M
    NAGAI, Y
    JOURNAL OF VIROLOGY, 1994, 68 (06) : 4075 - 4079
  • [27] EXPRESSION AND IMMUNOGENICITY OF THE EXTRACELLULAR DOMAIN OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN, GP160
    BERMAN, PW
    RIDDLE, L
    NAKAMURA, G
    HAFFAR, OK
    NUNES, WM
    SKEHEL, P
    BYRN, R
    GROOPMAN, J
    MATTHEWS, T
    GREGORY, T
    JOURNAL OF VIROLOGY, 1989, 63 (08) : 3489 - 3498
  • [28] IDENTIFICATION AND CHARACTERIZATION OF A NEUTRALIZATION SITE WITHIN THE 2ND VARIABLE REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120
    FUNG, MSC
    SUN, CRY
    GORDON, WL
    LIOU, RS
    CHANG, TW
    SUN, WNC
    DAAR, ES
    HO, DD
    JOURNAL OF VIROLOGY, 1992, 66 (02) : 848 - 856
  • [29] CHARACTERIZATION OF A DISCONTINUOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 EPITOPE RECOGNIZED BY A BROADLY REACTIVE NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY
    THALI, M
    OLSHEVSKY, U
    FURMAN, C
    GABUZDA, D
    POSNER, M
    SODROSKI, J
    JOURNAL OF VIROLOGY, 1991, 65 (11) : 6188 - 6193
  • [30] CONSTRUCTION OF A BINDING-SITE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 IN RAT CD4
    SCHOCKMEL, GA
    SOMOZA, C
    DAVIS, SJ
    WILLIAMS, AF
    HEALEY, D
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01): : 301 - 304